Study: Bone-strengthening drugs could backfire

NBC Nightly News with Brian Williams—March 10, 2010

The class of drugs designed to strengthen bones could have the opposite effect, according to recently released studies. The negative effect is present in only a very small percentage of patients.

Fosamax, Actonel and Boniva are widely used to counter the bone loss that leads to osteoporosis, mostly in older women. Two studies presented at a meeting of the American Academy of Orthopaedic Surgeons suggest that in a small portion of patients who used the drugs for over five years, the drugs could have an opposite effect: increasing the rate of a rare hip fracture.

“A small subpopulation could get a fracture from just walking across the street. It’s a brittle bone disease,” said Joseph Lane, M.D., an orthopedic trauma surgeon at Hospital for Special Surgery in New York.

The FDA says it is looking at the effects of the drugs. But it advises that people who are taking them not stop unless their doctors advise it. The research is still preliminary.

Watch the full report at msnbc.com.

 

Find a Physician

Conditions & Treatments

graphic: adult outline graphic: child outline
Select A Body Part
Conditions: Adult head Conditions: Adult spine Conditions: Adult shoulder Conditions: Adult elbow Conditions: Adult hand Conditions: Adult hip Conditions: Adult knee Conditions: Adult ankle Conditions: Adult head Conditions: Adult full body Conditions: Child spine Conditions: Child elbow Conditions: Child hip Conditions: Child hand Conditions: Child knee Conditions: Child ankle Conditions: Child full body

Complete Listing »

Media Contacts

Tracy Hickenbottom
Monique Irons
Sherry Randolph

212.606.1197
mediarelations@hss.edu

Social Media Contacts

Andrew Worob
Otis Gamboa
socialmediacontact@hss.edu